Skip to main content
. 2023 Sep 26;15(19):4155. doi: 10.3390/nu15194155

Table 2.

Concentration of selected metabolic indicators at different measurement points for both diets.

Indicator Measurement
Point
PD CD
Me (Q1; Q3) Me (Q1; Q3)
Glucose
(mmol/L)
baseline 5.05 (4.83; 5.40) 5.06 (4.94; 5.21)
4 4.96 (4.70; 5.18) 4.83 (4.58; 5.15)
8 4.99 (4.60; 5.33) 4.96 (4.77; 5.05)
Insulin
(µIU/mL)
baseline 7.13 (6.13; 8.75) 7.25 (5.37; 10.60)
4 6.60 (4.80; 9.72) 6.76 (5.95; 7.90)
8 6.32 (5.50; 8.48) 5.54 (4.72; 7.39)
FFA
(mmol/L)
baseline 0.52 (0.25; 0.68) 0.24 (0.15; 0.41)
4 0.35 (0.28; 0.57) 0.52 (0.22; 0.76)
8 0.29 (0.21; 0.54) 0.39 (0.19; 0.64)
β-HB
(mmol/L)
baseline 0.05 (0.04; 0.07) 0.05 (0.04; 0.15)
4 0.10 (0.05; 0.17) 0.08 (0.05; 0.21)
8 0.11 (0.04; 0.18) 0.08 (0.05; 0.12)
TC
(mmol/L)
baseline 3.83 (3.58; 4,31) 3.86 (3.52; 4.75)
4 4.35 (3.42; 4.65) 3.81 (3.49; 4.83)
8 4.26 (3.91; 4.72) 3.93 (3.66; 4.50)
HDL-C
(mmol/L)
baseline 1.39 (1.22; 1.91) 1.44 (1.22; 1.78)
4 1.39 (1.18; 1.69) 1.40 (1.09; 1.62)
8 1.53 (1.36; 1.86) 1.37 (1.11; 1.78)
non-HDL-C
(mmol/L)
baseline 2.53 (2.08; 2.99) 2.44 (1.95; 3.10)
4 2.75 (2.08; 3.21) 2.25 (1.99; 3.28)
8 2.78 (2.65; 3.10) 2.60 (1.85; 3.13)
LDL-C
(mmol/L)
baseline 2.06 (1.71; 2.52) 1.84 (1.56; 2.42)
4 2.47 (1.80; 2.86) 1.89 (1.67; 2.92)
8 2.26 (1.76; 2.67) 2.08 (1.53; 2.71)
TG
(mmol/dL)
baseline 1.07 (0.89; 1.67) 0.80 (0.70; 1.30)
4 0.76 (0.61; 1.05) 0.81 (0.69; 1.09)
8 0.97 (0.79; 1.15) 1.00 (0.68; 1.54)
Mean ± SD Mean ± SD
Adiponectin
(µg/mL)
baseline 4.54 ± 2.97 6.99 ± 5,61
4 4.62 ± 3.39 6.01 ± 4.30
8 5.14 ± 3.42 * 6.35 ± 4.74
Leptin
(ng/mL)
baseline 3.10 ±1.75 5.09 ± 5.27
4 1.86 ± 1.63 3.23 ± 3.78
8 2.41 ± 2.25 2.78 ± 3.16
Irisin
(µg/mL)
baseline 8.85 ± 3.36 9.16 ± 2.74
4 8.11 ± 3.24 8.04 ± 3.47
8 6.88 ± 2.64 6.59 ± 3.14

Abbreviations: PD—Paleo diet, CD—control diet, Me—median, Q1—upper quartile, Q3—lower quartile, SD—standard deviation, FFA—free fatty acids, β-HB-beta hydroxybutyrate, TC—total cholesterol, HDL-C—high-density lipoprotein cholesterol, non-HDL-C—non-high-density lipoprotein cholesterol, LDL-C—low-density lipoprotein cholesterol, TG—triglycerides, *—statistically significant intragroup differences compared with the baseline at the level p < 0.05.